ICON plc
The Site Engagement Study Manager is responsible for the end-to-end delivery, governance, and performance of site engagement activities across assigned clinical trials. This role serves as the primary point of contact for coordination, ensuring alignment with customer expectations, operational KPIs, and financial targets while driving execution accountability. The position leads cross-functional coordination, oversees customer reporting, and ensures site engagement strategies translate into measurable trial impact.
ICON plc is a global clinical research organisation (CRO) that provides outsourced clinical development and commercialisation services to pharmaceutical, biotechnology and medical device companies. It offers end-to-end drug and device development support — including clinical trial management across phases, data management and biostatistics, regulatory and safety/pharmacovigilance, and commercialisation and market-access services. ICON combines scientific and therapeutic expertise with technology and a scalable global operations network to accelerate development and bring therapies to patients. Clients engage ICON for integrated, experienced CRO support across the full product lifecycle.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ICON plc.
ICON plc didn’t post a salary, so this is our estimate from similar listings.
Senior Manager, Study Site Engagement
BioLife Plasma Services
Executive Director, Global Site & Study Operations, Americas
lifelancer
Study Site Engagement Lead
BioLife Plasma Services
Sr. Manager, Study Site Engagement
BioLife Plasma Services
Study Startup Specialist
Systimmune
Clinical Study Specialist
Regeneron Pharmaceuticals